Humana Inc
NYSE:HUM

Watchlist Manager
Humana Inc Logo
Humana Inc
NYSE:HUM
Watchlist
Price: 257.85 USD 1.91% Market Closed
Market Cap: 31B USD

During the last 3 months Humana Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on May 14, 2025 by Rechtin James A. , who bought 1.5m USD worth of HUM shares.

Last Transactions:
Rechtin James A.
$+1.5m
Huval Timothy S.
$-948.9k
Mesquita Jorge S.
$+200.1k
Diamond Susan M
$-1.4m
Broussard Bruce D
$-8.9m
Ventura Joseph C
$-1m
Huval Timothy S.
$-1.3m
Jones David A Jr/Ky
$-7.5m
Huval Timothy S.
$-316k
Broussard Bruce D
$-3.7m
Deshpande Samir
$-4.5m
Wheatley Timothy Alan
$-8.8m
Ventura Joseph C
$-1.5m
Fleming William Kevin
$-6.3m
Broussard Bruce D
$-5.1m
Diamond Susan M
$-2.2m
Huval Timothy S.
$-3.8m
Ventura Joseph C
$-621.3k
Deshpande Samir
$-1.7m
Fleming William Kevin
$-1.4m
Huval Timothy S.
$-1.5m
Broussard Bruce D
$-18.7m
Jones David A Jr/Ky
$-1.9m
Fleming William Kevin
$-3.5m
Wheatley Timothy Alan
$-1.5m
Hunter Christopher H.
$-2.3m
Huval Timothy S.
$-1.7m
Mesquita Jorge S.
$+151.3k
Diamond Susan M
$-594.1k
Fleming William Kevin
$-1.7m
Broussard Bruce D
$-10.4m
Huval Timothy S.
$-1.4m
View All Transactions

During the last 3 months Humana Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on May 14, 2025 by Rechtin James A. , who bought 1.5m USD worth of HUM shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
948.9k USD
1
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
1
1.5m USD
9-12
months
0
0 USD

Humana Inc
Insider Trading Chart

Humana Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Humana Inc
Last Insider Transactions

Global
Insiders Monitor

Humana Inc
Glance View

In the rapidly evolving landscape of American healthcare, Humana Inc. stands as a formidable player, interweaving its mission to improve public health with robust profitability. Founded in 1961, Humana began as a nursing home company and has since metamorphosed into one of the United States' leading health insurance and managed care providers. The company's core business revolves around offering diversified health insurance plans, with a strong emphasis on Medicare Advantage. This government-subsidized program allows private insurers to offer Medicare benefits, which Humana artfully packages with additional services like dental, vision, and wellness programs. This strategy not only broadens its appeal to the aging baby boomer demographic but also ensures a steady stream of revenue supported by federal payments. Humana's financial narrative is enriched by its commitment to integrating care delivery and health plan administration. Through strategic acquisitions and partnerships, the company has expanded its capabilities beyond traditional insurance, diving into health services such as primary care centers and home health services. This integration allows Humana to control costs more effectively, directly improving patient outcomes and enhancing customer loyalty. With data-driven insights and a proactive approach towards preventative care, Humana aligns its operations to both elevate the customer experience and drive down healthcare expenditures—cultivating a cycle that reinforces its market position and financial performance.

HUM Intrinsic Value
HIDDEN
Show

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top